Develops optogenetic control for industrial-scale precision fermentation
Loading investors…
Loading investors…
Activity from announced rounds
Develops optogenetic control for industrial-scale precision fermentation
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
Provides continuous hyper-fermentation technology for industrial-scale bio-production
Decodes the dark proteome using an AI-powered novel sequencing and discovery platform to reveal novel cancer targets
Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis
Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases
Develops high-performance topical solutions for body contouring and sustained aesthetic results
Develops custom chemical additives to enhance wild microbial communities for metal extraction